
NYSEHealthcareMedical - Diagnostics & Research
最新データ
$219.87
+$2.41 · +1.11%
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
前日終値
$219.87
+$2.41 · +1.11%
日中の時刻はETです。市場データは遅延する場合があります。
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
日中レンジ
現在 $219.87
52週レンジ
現在 $219.87
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
69
割安
センチメント
68
強気
リスク
30
中程度のリスク
モメンタム
48
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
日中レンジ
現在 $219.87
52週レンジ
現在 $219.87
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 245.68億 USD | 238.75億 USD | 238.9億 USD | 266.43億 USD | 294.53億 USD |
| 売上原価 | 95.98億 USD | 96.69億 USD | 98.56億 USD | 104.55億 USD | 115.01億 USD |
| 粗利益 | 149.7億 USD | 142.06億 USD | 140.34億 USD | 161.88億 USD | 179.52億 USD |
| 研究開発 | 15.98億 USD | 15.84億 USD | 15.03億 USD | 15.28億 USD | 17.42億 USD |
| 販売・一般管理 | 82.35億 USD | 74.38億 USD | 72.52億 USD | 71.24億 USD | 81.6億 USD |
| 営業費用 | 98.33億 USD | 90.22億 USD | 87.55億 USD | 86.52億 USD | 99.02億 USD |
| 受取利息 | 3000万 USD | 1.17億 USD | 3.03億 USD | 4100万 USD | 1100万 USD |
| 支払利息 | 2.65億 USD | 2.78億 USD | 2.89億 USD | 2.07億 USD | 2.41億 USD |
| 減価償却費と償却費 | 24.47億 USD | 23.52億 USD | 21.66億 USD | 21.32億 USD | 21.68億 USD |
| 営業利益 | 51.37億 USD | 51.84億 USD | 52.79億 USD | 75.36億 USD | 80.5億 USD |
| 純利益 | 36.14億 USD | 38.99億 USD | 47.64億 USD | 72.09億 USD | 64.33億 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
分割調整後の1株当たりの年間現金分配金。
$1.28
2025年(通年)+71.9% 以来 2021
2026年(一部):$1.20
$0.7447
2,021
$0.8865
2,022
$0.9887
2,023
$1.08
2,024
$1.28
2,025
$1.20
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年9月30日 | $0.40Quarterly | 2026年9月30日 | 2026年10月30日 |
配当 | 2026年6月26日 | $0.40Quarterly | 2026年6月26日 | 2026年7月31日 |
配当 | 2026年3月27日 | $0.40Quarterly | 2026年3月27日 | 2026年4月24日 |
配当 | 2025年12月26日 | $0.32Quarterly | 2025年12月26日 | 2026年1月30日 |
配当 | 2025年9月26日 | $0.32Quarterly | 2025年9月26日 | 2025年10月31日 |
配当 | 2025年6月27日 | $0.32Quarterly | 2025年6月27日 | 2025年7月25日 |
配当落ち 2026年9月30日
$0.40
Quarterly
2026年9月30日基準 · 支払日 2026年10月30日
配当落ち 2026年6月26日
$0.40
Quarterly
2026年6月26日基準 · 支払日 2026年7月31日
配当落ち 2026年3月27日
$0.40
Quarterly
2026年3月27日基準 · 支払日 2026年4月24日
配当落ち 2025年12月26日
$0.32
Quarterly
2025年12月26日基準 · 支払日 2026年1月30日
配当落ち 2025年9月26日
$0.32
Quarterly
2025年9月26日基準 · 支払日 2025年10月31日
配当落ち 2025年6月27日
$0.32
Quarterly
2025年6月27日基準 · 支払日 2025年7月25日
この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T2629.02億0.20%129.34兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI43.24億0.18%2.3兆 USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO35.74億0.20%1.8兆 USD0.03%$715.59+0.61%
iShares Core S&P 500 ETFIVV18.09億0.20%8927.95億 USD0.03%$781.97+0.60%
State Street SPDR S&P 500 ETFSPY16.61億0.20%8172億 USD0.09%$778.57+0.60%
Vanguard Morningstar Value ETFVTV13億0.50%2624億 USD0.03%$220.59+0.44%
State Street Health Care Select Sector SPDR ETFXLV9.69億2.23%435.37億 USD0.08%$170.81+1.58%
Vanguard Dividend Appreciation ETFVIG7.62億0.57%1324億 USD0.04%$239.05+0.70%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。